06/07 2022 Non-regulatory Redsense announces CEO succession date Redsense Medical announces that newly appointed Pontus Nobréus will take over as CEO of the Company starting the 1[st] of August 2022. Outgoing CEO Patrik… [read more]
11/05 2022 Non-regulatory Redsense to exhibit on the 59[th] ERA-EDTA congress Redsense Medical announces that the company will exhibit on this year’s ERA-EDTA conference in Paris, May 19-22. The European Renal Association (ERA) and the European… [read more]
02/05 2022 Regulatory Kommuniké från årsstämma i Redsense Medical AB (publ) den 2 maj 2021 Redsense Medical AB (publ) höll under onsdagen den 2 maj 2022 årsstämma varvid följande huvudsakliga beslut fattades. Samtliga beslut fattades med erforderlig majoritet. För detaljerad… [read more]
